Double Closure of Nasal Layer in Alveolar Cleft Grafting - Trial NCT05988086
Access comprehensive clinical trial information for NCT05988086 through Pure Global AI's free database. This phase not specified trial is sponsored by Tanta University and is currently Enrolling by invitation. The study focuses on Alveolar Cleft. Target enrollment is 24 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Tanta University
Timeline & Enrollment
N/A
Oct 10, 2022
Sep 30, 2023
Primary Outcome
visual analogue scale,inflammation score scale,density of bone
Summary
The aim of this prospective study is to evaluate both clinically and radiologically the
 efficacy of using autologous platelets rich fibrin versus collagen membrane for nasal layer
 closure in secondary alveolar cleft repair.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05988086
Non-Device Trial